Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding

Gennaro D'Amico, Angelo Luca

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Promoting the development of oesophageal varices and ascites, portal hypertension dominates the clinical course of cirrhosis. Varices appear in patients with portal pressure gradient above 10 mmHg and enlarge in 10-20% within 1-2 years of their detection. Bleeding occurs in patients with portal pressure gradient above 12 mmHg when the wall tension causes the rupture of varices, with an incidence of about 10% per year. Indicators of bleeding risk are portal pressure gradient, variceal pressure, large varices and liver dysfunction. Mortality per bleeding episode is 30-50%. Among survivors 60% will rebleed and 30% will die in the following year. The risk of rebleeding decreases in patients with spontaneous or treatment induced reduction of portal pressure gradinent or variceal pressure. Ascites develops in almost all patients along the course of the disease. Median survival after its appearance is less than 2 years. Less than 5% of cirrhotic patients die without ascites or without a previous bleeding. Thus portal hypertension is a major determinant of survival in cirrhosis.

Original languageEnglish
Pages (from-to)243-256
Number of pages14
JournalBailliere's Clinical Gastroenterology
Volume11
Issue number2
DOIs
Publication statusPublished - Jun 1997

Fingerprint

Portal Pressure
Natural History
Hemodynamics
Hemorrhage
Varicose Veins
Ascites
Portal Hypertension
Fibrosis
Pressure
Survival
Esophageal and Gastric Varices
Survivors
Liver Diseases
Rupture
Mortality
Incidence
Therapeutics

Keywords

  • Natural history of cirrhosis
  • Oesophageal varices
  • Portal hypertension
  • Variceal bleeding risk indicators

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. / D'Amico, Gennaro; Luca, Angelo.

In: Bailliere's Clinical Gastroenterology, Vol. 11, No. 2, 06.1997, p. 243-256.

Research output: Contribution to journalArticle

@article{722439f7641c41068035c6c4c3db9f08,
title = "Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding",
abstract = "Promoting the development of oesophageal varices and ascites, portal hypertension dominates the clinical course of cirrhosis. Varices appear in patients with portal pressure gradient above 10 mmHg and enlarge in 10-20{\%} within 1-2 years of their detection. Bleeding occurs in patients with portal pressure gradient above 12 mmHg when the wall tension causes the rupture of varices, with an incidence of about 10{\%} per year. Indicators of bleeding risk are portal pressure gradient, variceal pressure, large varices and liver dysfunction. Mortality per bleeding episode is 30-50{\%}. Among survivors 60{\%} will rebleed and 30{\%} will die in the following year. The risk of rebleeding decreases in patients with spontaneous or treatment induced reduction of portal pressure gradinent or variceal pressure. Ascites develops in almost all patients along the course of the disease. Median survival after its appearance is less than 2 years. Less than 5{\%} of cirrhotic patients die without ascites or without a previous bleeding. Thus portal hypertension is a major determinant of survival in cirrhosis.",
keywords = "Natural history of cirrhosis, Oesophageal varices, Portal hypertension, Variceal bleeding risk indicators",
author = "Gennaro D'Amico and Angelo Luca",
year = "1997",
month = "6",
doi = "10.1016/S0950-3528(97)90038-5",
language = "English",
volume = "11",
pages = "243--256",
journal = "Bailliere's Clinical Gastroenterology",
issn = "0950-3528",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding

AU - D'Amico, Gennaro

AU - Luca, Angelo

PY - 1997/6

Y1 - 1997/6

N2 - Promoting the development of oesophageal varices and ascites, portal hypertension dominates the clinical course of cirrhosis. Varices appear in patients with portal pressure gradient above 10 mmHg and enlarge in 10-20% within 1-2 years of their detection. Bleeding occurs in patients with portal pressure gradient above 12 mmHg when the wall tension causes the rupture of varices, with an incidence of about 10% per year. Indicators of bleeding risk are portal pressure gradient, variceal pressure, large varices and liver dysfunction. Mortality per bleeding episode is 30-50%. Among survivors 60% will rebleed and 30% will die in the following year. The risk of rebleeding decreases in patients with spontaneous or treatment induced reduction of portal pressure gradinent or variceal pressure. Ascites develops in almost all patients along the course of the disease. Median survival after its appearance is less than 2 years. Less than 5% of cirrhotic patients die without ascites or without a previous bleeding. Thus portal hypertension is a major determinant of survival in cirrhosis.

AB - Promoting the development of oesophageal varices and ascites, portal hypertension dominates the clinical course of cirrhosis. Varices appear in patients with portal pressure gradient above 10 mmHg and enlarge in 10-20% within 1-2 years of their detection. Bleeding occurs in patients with portal pressure gradient above 12 mmHg when the wall tension causes the rupture of varices, with an incidence of about 10% per year. Indicators of bleeding risk are portal pressure gradient, variceal pressure, large varices and liver dysfunction. Mortality per bleeding episode is 30-50%. Among survivors 60% will rebleed and 30% will die in the following year. The risk of rebleeding decreases in patients with spontaneous or treatment induced reduction of portal pressure gradinent or variceal pressure. Ascites develops in almost all patients along the course of the disease. Median survival after its appearance is less than 2 years. Less than 5% of cirrhotic patients die without ascites or without a previous bleeding. Thus portal hypertension is a major determinant of survival in cirrhosis.

KW - Natural history of cirrhosis

KW - Oesophageal varices

KW - Portal hypertension

KW - Variceal bleeding risk indicators

UR - http://www.scopus.com/inward/record.url?scp=0030728035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030728035&partnerID=8YFLogxK

U2 - 10.1016/S0950-3528(97)90038-5

DO - 10.1016/S0950-3528(97)90038-5

M3 - Article

VL - 11

SP - 243

EP - 256

JO - Bailliere's Clinical Gastroenterology

JF - Bailliere's Clinical Gastroenterology

SN - 0950-3528

IS - 2

ER -